This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Pterygium, Bevacizumab, VEGF or Anti-VEGF
and you are
over 30
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The purpose of this study is to determine whether bevacizumab eye drop is effective in the treatment of recurrent pterygium.

Provided treatments

  • Drug: bevacizumab eye drop 0.05%
  • Drug: normal saline 0.9%

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01311960. The sponsor of the trial is Chulalongkorn University and it is looking for 24 volunteers for the current phase.
Official trial title:
Topical Bevacizumab 0.05% Eye Drops for Preventing Recurrent Pterygium, A Randomized, Double-masked, Controlled Trial